Impact Biomedical Inc. (IBO)
Market Closed
11 Jun, 20:00
AMEX AMEX Primary $
0. 56
-0.01
-1.5817%
$
7M Market Cap
- P/E Ratio
- Div Yield
58,139 Volume
- Eps
$ 0.57
Previous Close Want to track IBO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
IBO closed today lower at $0.56, a decrease of -1.5817% from yesterday's close, completing a monthly decrease of -16.5425% or -$0.11. Over the past 12 months, IBO stock gained 12%.
IBO pays dividends to its shareholders, with the most recent payment made on Jun 05, 2020. The next estimated payment will be in 5 Jul 2020 on Jul 05, 2020 for a total of $0.1242.
The last earnings report, released on Mar 27, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on one exchange.
Impact Biomedical Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| TM Thomas Mason Mason & Associates Inc. | 10,000 | $6,648 | $5,600 | -$1,048 | -15.76% |
| MM Mark Mowrey Signature Resources Capital Management LLC | 4 | $3.48 | $2.24 | -$1.24 | -35.63% |
Impact Biomedical Inc. (IBO) FAQ
What is the stock price today?
The current price is $0.56.
On which exchange is it traded?
Impact Biomedical Inc. is listed on AMEX.
What is its stock symbol?
The ticker symbol is IBO.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 7M.
Has Impact Biomedical Inc. ever had a stock split?
No, there has never been a stock split.
Impact Biomedical Inc. Profile
| Biotechnology Industry | Healthcare Sector | Frank D. Heuszel CEO | AMEX Exchange | 45259L205 CUSIP |
| US Country | 2 Employees | - Last Dividend | - Last Split | - IPO Date |
Overview
Impact BioMedical Inc. is a biopharmaceutical company focusing on the discovery and development of innovative healthcare solutions, with a strong emphasis on specialty biopharmaceuticals and consumer healthcare. Since its establishment in 2018, the company has dedicated itself to creating advanced treatment options and products designed to address complex health challenges. Based in Houston, Texas, Impact BioMedical operates at the forefront of medical science, leveraging extensive research and development efforts to tackle diseases and conditions in areas such as oncology, inflammatory disorders, and neurology, among others.
Products and Services
Impact BioMedical Inc. has developed a range of groundbreaking technologies and platforms, including:
- Linebacker: This is a platform comprised of small molecule electrophilically enhanced polyphenol compounds. It exhibits potential applications in several critical areas of healthcare, including oncology for cancer treatment, various inflammatory disorders to reduce inflammation and pain, and neurology for managing neurological conditions.
- Laetose Technology: Originating from a novel combination of sugar and inositol, Laetose aims at mitigating the inflammatory and metabolic responses commonly associated with sugar intake. This technology represents a significant step forward in the pursuit of healthier sugar alternatives that do not compromise the body's metabolic health.
- Functional Fragrance Formulation: Impact BioMedical has developed a unique suite of functional fragrances, which incorporate specialized botanical ingredients. These fragrances have diverse applications, including serving as antimicrobials and additives in various consumer products like insect repellents, detergents, lotions, shampoos, fabrics, and more. This innovation not only aims to improve product effectiveness but also enhance user experience through the therapeutic benefits of fragrance.
- Equivir/Equivir G Technology: This novel blend of polyphenols offers promising antiviral effects, which can be leveraged in health supplements and medications. The Equivir family of products showcases Impact BioMedical’s commitment to developing antiviral solutions that can be integrated into everyday health regimens, offering a preventive approach to viral infections.
Contact Information
Address: 1400 Broadfield Blvd.
Phone: 585-325-3610
Website: https://www.impactbiomedinc.com
